$44.00
1.88[4.46%]
At close: Apr 29
$44.00
0[0.00%]
After Hours: 4:00PM EDT
Crinetics Pharmaceuticals
(NASDAQ:CRNX)Crinetics Pharmaceuticals Stock (NASDAQ:CRNX), Insider Trading Activity
Crinetics Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
78.744M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0 | $30.68 | -$396.46K | SELL-OPTIONS | 0.00% | 27.786K | Apr 15 | View |
| Apr 08, 2024 | Scott Richard Struthers | PRESIDENT & CEO | 0 | $29.23 | -$1.63M | SELL-OPTIONS | 0.00% | 238.835K | Apr 04 | View |
| Apr 02, 2024 | Stephanie Okey | DIRECTOR | 0 | $32.34 | -$491.57K | SELL-OPTIONS | 0.00% | 6K | Mar 28 | View |
| Mar 26, 2024 | Jeff Knight | CHIEF OPERATING OFFICER | -2.359K | $34.14 | -$714.28K | SELL | -4.29% | 52.58K | Mar 22 | View |
| Mar 22, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | -714 | $30.47 | -$421.97K | SELL | -2.51% | 27.786K | Mar 20 | View |
| Mar 22, 2024 | Matthew Fust | DIRECTOR | 0 | $32.53 | -$1.39M | SELL-OPTIONS | 0.00% | 18.536K | Mar 20 | View |
| Mar 20, 2024 | Marc Wilson | CFO | -10.925K | $41.17 | -$449.79K | SELL | -8.99% | 110.63K | Mar 18 - Mar 19 | View |
| Jan 26, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3K | $37.26 | -$111.78K | SELL | -3.93% | 73.298K | Jan 25 | View |
| Jan 12, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3K | $37.65 | -$112.95K | SELL | -3.78% | 76.298K | Jan 10 | View |
| Jan 04, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0 | $25.95 | -$260.33K | SELL-OPTIONS | 0.00% | 5.911K | Jan 03 | View |
| Jan 04, 2024 | Marc Wilson | CFO | 0 | $22.38 | -$261.90K | SELL-OPTIONS | 0.00% | 96.055K | Jan 02 | View |
| Dec 27, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3K | $35.89 | -$107.67K | SELL | -3.65% | 79.298K | Dec 26 | View |
| Dec 22, 2023 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0 | $25.73 | -$169.43K | SELL-OPTIONS | 0.00% | 5.911K | Dec 21 | View |
| Dec 13, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3K | $32.87 | -$98.61K | SELL | -3.52% | 82.298K | Dec 11 | View |
| Nov 29, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3K | $31.84 | -$95.52K | SELL | -3.40% | 85.298K | Nov 27 | View |
| Nov 06, 2023 | Scott Richard Struthers | PRESIDENT & CEO | 0 | $19.92 | -$4.26M | SELL-OPTIONS | 0.00% | 225.522K | Nov 02 - Nov 03 | View |
| Nov 03, 2023 | Marc Wilson | CFO | 0 | $19.02 | -$194.70K | SELL-OPTIONS | 0.00% | 95.601K | Nov 01 | View |
| Oct 19, 2023 | Seth Alan Krasner | CHIEF MEDICAL OFFICER | 0 | $21.00 | -$125.93K | SELL-OPTIONS | 0.00% | 43.21K | Oct 17 | View |
| Jul 13, 2023 | Scott Richard Struthers | PRESIDENT & CEO | -50K | $20.21 | -$1.01M | SELL | -6.49% | 720.805K | Jul 11 - Jul 13 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.